Robert T. Koda

678 total citations
35 papers, 520 citations indexed

About

Robert T. Koda is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Robert T. Koda has authored 35 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Robert T. Koda's work include Glaucoma and retinal disorders (4 papers), Cancer therapeutics and mechanisms (4 papers) and Analytical Chemistry and Chromatography (3 papers). Robert T. Koda is often cited by papers focused on Glaucoma and retinal disorders (4 papers), Cancer therapeutics and mechanisms (4 papers) and Analytical Chemistry and Chromatography (3 papers). Robert T. Koda collaborates with scholars based in United States, Brazil and Singapore. Robert T. Koda's co-authors include Eric J. Lien, John A. Biles, John K. Haleblian, Steve K.L. Seah, João Antônio Prata, Franco M. Muggia, Dale K. Heuer, George Baerveldt, Don S. Minckler and Paul P. Lee and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Robert T. Koda

33 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert T. Koda United States 15 102 77 69 63 56 35 520
Víctor Mangas‐Sanjuán Spain 10 101 1.0× 80 1.0× 72 1.0× 52 0.8× 47 0.8× 45 425
Hossein M. Elbadawy Saudi Arabia 13 148 1.5× 29 0.4× 114 1.7× 36 0.6× 58 1.0× 50 570
Hisashi Takasugi Japan 19 301 3.0× 13 0.2× 22 0.3× 201 3.2× 26 0.5× 92 1.6k
Philippe Arnaud France 13 127 1.2× 22 0.3× 18 0.3× 23 0.4× 139 2.5× 29 607
Deep Kwatra United States 16 238 2.3× 14 0.2× 49 0.7× 48 0.8× 80 1.4× 28 810
Jignesh Patel United States 10 110 1.1× 22 0.3× 26 0.4× 37 0.6× 88 1.6× 12 462
Popat Kumbhar India 14 194 1.9× 14 0.2× 19 0.3× 30 0.5× 166 3.0× 60 645
Henri Humbert France 15 77 0.8× 6 0.1× 12 0.2× 56 0.9× 43 0.8× 33 590

Countries citing papers authored by Robert T. Koda

Since Specialization
Citations

This map shows the geographic impact of Robert T. Koda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Koda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Koda more than expected).

Fields of papers citing papers by Robert T. Koda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Koda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Koda. The network helps show where Robert T. Koda may publish in the future.

Co-authorship network of co-authors of Robert T. Koda

This figure shows the co-authorship network connecting the top 25 collaborators of Robert T. Koda. A scholar is included among the top collaborators of Robert T. Koda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert T. Koda. Robert T. Koda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bading, James R., Antranik Shahinian, George W. Koszalka, et al.. (2004). Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-d-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nuclear Medicine and Biology. 31(4). 407–418. 30 indexed citations
2.
Koda, Robert T., et al.. (2001). Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's Wort preparations. Journal of Pharmaceutical and Biomedical Analysis. 26(5-6). 959–965. 31 indexed citations
3.
García, Agustin A., Franco M. Muggia, Colin Paul Spears, et al.. (2001). Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2′-deoxyuridine and leucovorin. Anti-Cancer Drugs. 12(6). 505–511. 4 indexed citations
4.
Koda, Robert T., et al.. (2000). Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey. Birkhäuser Basel eBooks. 55. 81–103. 26 indexed citations
5.
García, Agustin A., et al.. (1998). Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumors.. Journal of Clinical Oncology. 16(9). 2959–2963. 7 indexed citations
6.
7.
Pujari, Mahesh P., et al.. (1997). Determination of hydroxyurea in plasma and peritoneal fluid by high-performance liquid chromatography using electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 694(1). 185–191. 19 indexed citations
8.
Elkayam, Uri, et al.. (1996). Evidence for attenuated heart rate control with beta blockade in women with heart disease during pregnancy: A pharmacokinetic and pharmacodynamic study. Journal of the American College of Cardiology. 27(2). 79–79. 1 indexed citations
9.
Shetty, Bhasker V., et al.. (1995). High-performance liquid chromatographic method for the determination of a novel thymidylate synthase inhibitor, AG 331, in human serum. Journal of Chromatography B Biomedical Sciences and Applications. 673(2). 281–288.
10.
Hurst, Agneta K., et al.. (1995). High-Performance Liquid Chromatographic Method for Determination of Atenolol from Human Plasma and Urine: Simultaneous Fluorescence and Ultraviolet Detection. Journal of Liquid Chromatography. 18(4). 791–806. 13 indexed citations
11.
Seah, Steve K.L., João Antônio Prata, Don S. Minckler, et al.. (1993). Mitomycin-C concentration in human aqueous humour following trabeculectomy. Eye. 7(5). 652–655. 51 indexed citations
12.
Seah, Steve K.L., et al.. (1993). Determination of mitomycin C in human aqueous humor and serum by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 619(1). 148–153. 14 indexed citations
13.
Sattler, Fred R., Richard H. Ko, Diana Antoniskis, et al.. (1991). Acetaminophen Does Not Impair Clearance of Zidovudine. Annals of Internal Medicine. 114(11). 937–940. 15 indexed citations
14.
Koda, Robert T., et al.. (1990). Determination of the antimitotic agents N-Desacetylcolchicine, demecolcine and colchicine in serum and urine. Journal of Chromatography B Biomedical Sciences and Applications. 525(2). 411–418. 14 indexed citations
15.
Hu, Eddie, Richard H. Ko, Robert T. Koda, et al.. (1990). Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignancies. Cancer Chemotherapy and Pharmacology. 26(5). 359–364. 9 indexed citations
16.
Koda, Robert T., et al.. (1988). The Ocular Distribution of Bunolol in the Eyes of Albino and Pigmented Rabbits. Journal of Ocular Pharmacology and Therapeutics. 4(1). 37–42. 9 indexed citations
17.
Lien, Eric J., et al.. (1986). Oculotoxicities of Systemically Administered Drugs. Journal of Ocular Pharmacology and Therapeutics. 2(4). 385–404. 29 indexed citations
18.
McGhan, William F., et al.. (1982). Hospital pharmacists' attitudes towards medical services representatives: a comparison of directors, staff, and clinical pharmacists.. PubMed. 17(7). 957–61. 1 indexed citations
19.
Koda, Robert T., et al.. (1977). Fluorometric Determination of Methyldopa in Biological Fluids. Journal of Pharmaceutical Sciences. 66(11). 1632–1634. 27 indexed citations
20.
Lien, Eric J., et al.. (1974). Diffusion of Drugs into Prostatic Fluid and Milk. Drug Intelligence & Clinical Pharmacy. 8(8). 470–475. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026